Physician

Adrian Dobrescu, M.D.

According to 2025 Medicare claims, Adrian Dobrescu, M.D. (NPI: 1336316959) practices dermatology in the Gulfport-Biloxi, MS market, with the plurality of this provider's patient population coming from Harrison, MS. This provider's primary affiliated billing organization is NOLA DERMATOLOGY (NPI: 1629769138; TIN: 473881696) and primary practice location at 39531-4044.

Dobrescu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 154 traditional Medicare patients, billed 2,989 HCPCS/CPT codes, and received $245,517 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 462 prescription claims across 166 beneficiaries totaling $12,989 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 66 records totaling $1,719. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $43,832 and ending at $245,517. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $42,700 to $12,989. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$123K$246K2015 Medicare payment: $43,832 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $116,722 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $128,870 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $97,919 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $145,287 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $185,278 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $117,901 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $52,562 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $81,197 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $245,517 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015981,195$43,832
20161872,751$116,722
20172482,344$128,870
20182391,524$97,919
20193032,387$145,287
20203622,947$185,278
20211951,773$117,901
202295912$52,562
20231191,360$81,197
20241542,989$245,517

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$43K2015 Drug cost: $42,700 (USD; Tot_Drug_Cst)2016 Drug cost: $17,581 (USD; Tot_Drug_Cst)2017 Drug cost: $10,897 (USD; Tot_Drug_Cst)2018 Drug cost: $3,309 (USD; Tot_Drug_Cst)2019 Drug cost: $7,282 (USD; Tot_Drug_Cst)2020 Drug cost: $8,321 (USD; Tot_Drug_Cst)2021 Drug cost: $9,567 (USD; Tot_Drug_Cst)2022 Drug cost: $11,814 (USD; Tot_Drug_Cst)2023 Drug cost: $9,129 (USD; Tot_Drug_Cst)2024 Drug cost: $12,989 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015306651$42,700
2016119278$17,581
201788214$10,897
201866129$3,309
2019111217$7,282
2020142305$8,321
2021168348$9,567
2022132261$11,814
2023108296$9,129
2024166462$12,989

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths116162$115
11102Biopsy of related skin growth, first growth105142$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more133276$59
17000Destruction of precancer skin growth, 1 growth84127$35
17003Destruction of precancer skin growth, 2-14 growths831,451$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole902,539$2,304
TretinoinTretinoin23705$1,786
FluorouracilFluorouracil25684$1,684
ImiquimodImiquimod23785$842
Triamcinolone AcetonideTriamcinolone Acetonide611,541$682

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.66$1,719GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adrian Dobrescu, M.D.?

Tedicare shows public-source Medicare data for Adrian Dobrescu, M.D. (NPI 1336316959), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Dobrescu, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adrian Dobrescu, M.D.?

Adrian Dobrescu, M.D. is linked to NOLA DERMATOLOGY (billing NPI 1629769138) in the available physician profile data.

Does Adrian Dobrescu, M.D. have Open Payments data?

Adrian Dobrescu, M.D. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.